BioRender 아이콘

Enterocyte (epithelial���mesenchymal transition, stage 4)

Enterocyte (epithelial–mesenchymal transition, stage 4) - Editable icon of a spindle-shaped mesenchymal cell that has undergone  epithelial-mesenchymal transition, stage 4 of 4

[{"image":"https://icons.cdn.biorender.com/w75xh75/5ca75bc01177743300099897/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca75bc01177743300099897/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca75bc01177743300099895/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca75bc01177743300099895/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236c/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236d/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236d/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236e/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236e/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d236f/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d236f/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2370/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2370/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2371/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2371/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2372/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2372/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2373/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2373/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2374/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2374/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2375/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2375/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2376/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2376/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2377/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2377/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2378/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2378/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2379/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2379/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237a/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237a/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237c/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237d/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237d/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237e/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237e/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d237f/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d237f/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2380/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2380/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2381/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2381/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2382/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2382/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2383/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2383/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2384/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2384/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2385/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2385/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2386/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2386/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2387/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2387/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2388/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2388/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2389/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2389/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238a/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238a/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238c/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238d/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238d/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238e/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238e/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d238f/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d238f/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2390/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2390/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2391/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2391/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2392/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2392/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2393/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2393/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2394/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2394/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2395/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2395/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2396/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2396/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2397/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2397/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2398/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2398/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d2399/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d2399/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d239a/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d239a/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d239b/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d239b/5ca75b9a117774330009988e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f4ec5a4ff7a190d239c/5ca75b9a117774330009988e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f4ec5a4ff7a190d239c/5ca75b9a117774330009988e.png"}]

이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right

intestine,gi,gastrointestinal,intestinal,enterocyte,columnar cell,ciliated,epithelial cell,mesenchymal cell,stem cell,healing,wound,fibrosis,metastasis,cancer,epithelial,mesenchymal,EMT,transition,epithelial to mesenchymal transition,oncology

더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Enterocyte (epithelial���mesenchymal transition, stage 4) icon JPEG

Enterocyte (epithelial���mesenchymal transition, stage 4) icon PNG

Enterocyte (epithelial���mesenchymal transition, stage 4) icon SVG

Enterocyte (epithelial���mesenchymal transition, stage 4) icon GIF

BioRender 아이콘 FAQ

How are scientists using the Enterocyte (epithelial���mesenchymal transition, stage 4) icon in their work?

BioRender users often use the Enterocyte (epithelial���mesenchymal transition, stage 4) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Enterocyte (epithelial���mesenchymal transition, stage 4) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Enterocyte (epithelial���mesenchymal transition, stage 4) icon customizable in BioRender?

Most icons in BioRender, including the Enterocyte (epithelial���mesenchymal transition, stage 4) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Enterocyte (epithelial���mesenchymal transition, stage 4) icon for publication or presentations?

Yes, figures containing the Enterocyte (epithelial���mesenchymal transition, stage 4) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Enterocyte (epithelial���mesenchymal transition, stage 4) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Enterocyte (epithelial���mesenchymal transition, stage 4) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Enterocyte (epithelial���mesenchymal transition, stage 4) icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon